Partners Group, one of the largest firms in the global private markets industry, which invested in a majority stake in FairJourney Biologics in 2024 on behalf of its clients, will be represented ...

Partners Group Private Equity Ltd (LSE:PEY) reports robust annual performance with strategic exits and a focus on capital allocation, despite facing macroeconomic challenges.

2025--(BUSINESS WIRE)--FairJourney Biologics S.A., global leader in antibody discovery and development, today announced the formation of its Supervisory Board to support the Company’s ongoing ...

The acquisition of the South San Francisco site, formerly Distributed Bio, will transfer ownership of all facilities, staff and assets to FairJourney Biologics, including proprietary technologies ...

PORTO, Portugal & SAN FRANCISCO--(BUSINESS WIRE)--FairJourney Biologics S.A., leaders ... our ability to deliver innovative solutions to our partners. Working together, we can push the boundaries ...

FairJourney Biologics S.A., leaders in the ... but also enhance our ability to deliver innovative solutions to our partners. Working together, we can push the boundaries of antibody discovery ...